NQVRX | VMVAX | NQVRX / VMVAX | |
Total Expense Ratio | 0.91 | 0.07 | 1,300% |
Annual Report Gross Expense Ratio | 0.92 | 0.07 | 1,314% |
Fund Existence | 28 years | 14 years | - |
Gain YTD | 2.053 | -0.023 | -9,059% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 491M | 29.9B | 2% |
Annual Yield % from dividends | 1.53 | 2.31 | 66% |
Returns for 1 year | 12.61 | 7.23 | 174% |
Returns for 3 years | 55.86 | 24.99 | 224% |
Returns for 5 years | 124.51 | 69.23 | 180% |
Returns for 10 years | 134.75 | 78.81 | 171% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WCMEX | 16.83 | -0.11 | -0.65% |
WCM Focused Emerging Markets Instl | |||
PNBCX | 27.81 | -0.29 | -1.03% |
Virtus NFJ Large-Cap Value C | |||
OTCGX | 22.12 | -0.28 | -1.25% |
MFS Mid Cap Growth R1 | |||
FEMAX | 10.92 | -0.17 | -1.53% |
First Eagle U.S. SMID Cap Opportunity A | |||
TIOHX | 16.11 | -0.26 | -1.59% |
Nuveen International Opps I |